| 11/02/2026 5:02 AM | Vivos Therapeutics (1716166) Filer | Form DEFA14A | |
| 10/29/2026 2:55 PM | Vivos Therapeutics (1716166) Filer | Form DEF 14A | |
| 10/26/2026 8:52 PM | Lindsay Mark F. (1835542) Reporting Vivos Therapeutics (1716166) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/26/2026 7:06 PM | Green Ralph Elias (1835785) Reporting Vivos Therapeutics (1716166) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2026 6:00 AM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/19/2026 3:58 PM | Vivos Therapeutics (1716166) Filer | Form PRE 14A | |
| 10/19/2026 3:49 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2026 7:45 AM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2026 8:54 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2026 7:17 PM | JOHNSON GREGG C (1135957) Reporting Vivos Therapeutics (1716166) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 7:20 PM | SOKOLOW LEONARD J (923890) Reporting Vivos Therapeutics (1716166) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VVOS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vivos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/18/2026 4:04 PM | Huntsman Ronald Kirk (1835498) Reporting Vivos Therapeutics (1716166) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/08/2026 4:29 PM | Vivos Therapeutics (1716166) Filer | Form 8-K/A | |
| 08/26/2026 3:10 PM | Amman Bradford K. (1425339) Reporting Vivos Therapeutics (1716166) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 4:30 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 9:29 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Vivos Therapeutics (1716166) Subject | Form SCHEDULE 13G/A | |
| 08/11/2026 4:02 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/11/2026 12:28 PM | Streeterville Capital LLC (1851416) Filed by Vivos Therapeutics (1716166) Subject | Form SCHEDULE 13G | |
| 08/03/2026 4:29 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/15/2026 4:07 PM | V-Co Investors 4 LLC (2137034) Filed by Vivos Therapeutics (1716166) Subject | Form SCHEDULE 13D | |
| 07/15/2026 3:22 PM | V-Co Investors 4 LLC (2137034) Reporting Vivos Therapeutics (1716166) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/15/2026 3:23 PM | Skaff Michael C (2074003) Reporting Vivos Therapeutics (1716166) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 4:29 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/25/2026 4:22 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2026 4:03 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/08/2026 7:30 AM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 4:05 PM | Vivos Therapeutics (1716166) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/15/2026 10:05 AM | ARMISTICE CAPITAL, LLC (1601086) Filed by Vivos Therapeutics (1716166) Subject | Form SCHEDULE 13G | |
| 05/10/2026 11:15 PM | Vivos Therapeutics (1716166) Filer | Form EFFECT | |
| 04/29/2026 6:15 PM | Vivos Therapeutics (1716166) Filer | Form S-3/A | |
| 04/22/2026 3:25 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 4:15 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/15/2026 4:00 PM | Vivos Therapeutics (1716166) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 04/10/2026 3:54 PM | V-Co Investors 3 LLC (2114460) Reporting Vivos Therapeutics (1716166) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/03/2026 3:05 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/02/2026 6:34 PM | Skaff Michael C (2074003) Reporting V-Co Investors 3 LLC (2114460) Reporting Vivos Therapeutics (1716166) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 5:32 PM | V-Co Investors 3 LLC (2114460) Filed by Vivos Therapeutics (1716166) Subject | Form SCHEDULE 13D | |
| 02/13/2026 7:36 PM | JOHNSON GREGG C (1135957) Reporting Vivos Therapeutics (1716166) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 01/20/2026 3:05 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/14/2026 3:05 PM | Vivos Therapeutics (1716166) Filer | Form 424B3 | |
| 01/07/2026 11:15 PM | Vivos Therapeutics (1716166) Filer | Form EFFECT | |
Every Starlink dish pays this stock (Ad) There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it.
Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th.
This free pick names the public company collecting on every unit. Claim your free stock pick before December 8th |
| 01/02/2026 3:44 PM | Vivos Therapeutics (1716166) Filer | Form POS AM | |
| 12/05/2025 4:12 PM | Vivos Therapeutics (1716166) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |